Literature DB >> 7271847

Interaction of 2-formylpyridine thiosemicarbazonato copper (II) with Ehrlich ascites tumor cells.

L A Saryan, K Mailer, C Krishnamurti, W Antholine, D H Petering.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7271847     DOI: 10.1016/0006-2952(81)90386-5

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  9 in total

1.  A copper chelate of thiosemicarbazone NSC 689534 induces oxidative/ER stress and inhibits tumor growth in vitro and in vivo.

Authors:  Chad N Hancock; Luke H Stockwin; Bingnan Han; Raymond D Divelbiss; Jung Ho Jun; Sanjay V Malhotra; Melinda G Hollingshead; Dianne L Newton
Journal:  Free Radic Biol Med       Date:  2010-11-04       Impact factor: 7.376

2.  Mechanisms underlying reductant-induced reactive oxygen species formation by anticancer copper(II) compounds.

Authors:  Christian R Kowol; Petra Heffeter; Walter Miklos; Lars Gille; Robert Trondl; Loredana Cappellacci; Walter Berger; Bernhard K Keppler
Journal:  J Biol Inorg Chem       Date:  2011-12-22       Impact factor: 3.358

3.  Cytotoxic Evaluation of 3-Aminopyridine-2-Carboxaldehyde Thiosemicarbazone, 3-AP, in Peripheral Blood Lymphocytes of Patients with Refractory Solid Tumors using Electron Paramagnetic Resonance.

Authors:  Jill M Kolesar; Kamakshi Sachidanandam; William R Schelman; Jens Eickhoff; Kyle D Holen; Anne M Traynor; Dona B Alberti; James P Thomas; Christopher R Chitambar; George Wilding; William E Antholine
Journal:  Exp Ther Med       Date:  2011-01       Impact factor: 2.447

Review 4.  Antifungal and antitumor activity of heterocyclic thiosemicarbazones and their metal complexes: current status.

Authors:  A E Liberta; D X West
Journal:  Biometals       Date:  1992       Impact factor: 2.949

5.  Electron paramagnetic resonance study of peripheral blood mononuclear cells from patients with refractory solid tumors treated with Triapine.

Authors:  Jill M Kolesar; William R Schelman; Peter G Geiger; Kyle D Holen; Anne M Traynor; Dona B Alberti; James P Thomas; Christopher R Chitambar; George Wilding; William E Antholine
Journal:  J Inorg Biochem       Date:  2007-10-30       Impact factor: 4.155

Review 6.  Anticancer activity of metal complexes: involvement of redox processes.

Authors:  Ute Jungwirth; Christian R Kowol; Bernhard K Keppler; Christian G Hartinger; Walter Berger; Petra Heffeter
Journal:  Antioxid Redox Signal       Date:  2011-05-11       Impact factor: 8.401

7.  ESR of copper and iron complexes with antitumor and cytotoxic properties.

Authors:  W E Antholine; B Kalyanaraman; D H Petering
Journal:  Environ Health Perspect       Date:  1985-12       Impact factor: 9.031

8.  Mechanistic characterization of a copper containing thiosemicarbazone with potent antitumor activity.

Authors:  Henning Karlsson; Mårten Fryknäs; Sara Strese; Joachim Gullbo; Gunnar Westman; Ulf Bremberg; Tobias Sjöblom; Tatjana Pandzic; Rolf Larsson; Peter Nygren
Journal:  Oncotarget       Date:  2017-05-02

9.  Cytotoxic and Antitumour Studies of Acetoacetanilide N(4)-methyl(phenyl)thiosemicarbazone and its Transition Metal Complexes.

Authors:  N P Priya; A P Firdous; R Jeevana; K K Aravindakshan
Journal:  Indian J Pharm Sci       Date:  2015 Nov-Dec       Impact factor: 0.975

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.